Latest Marketing Strategy News

CleanSpace Holdings posted a robust 26% revenue increase in FY25, turning the corner to positive EBITDA and cash flow in the second half, driven by strong industrial market demand and operational efficiencies.

CleanSpace Holdings Limited reported a 26% increase in revenue to $19.8 million for FY25, alongside a significant reduction in net loss to $478,276. The company’s strategic expansion and innovation efforts underpin its improving financial health and global market presence.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.

GQG Partners Inc. reported robust first-half 2025 results with revenue up 11% and net income rising 14.4%, alongside a new US ETF launch and a declared interim dividend.

Orbital Corporation reveals a strategic pivot amid evolving US drone policies, with a new management team driving growth beyond Boeing Insitu. FY25 guidance shows revenue decline but promising new contracts.

Po Valley Energy and its partners have inked a 12-month gas sales agreement with Hera Trading, marking a strategic shift from BP Gas Marketing and reinforcing local ties in Italy’s energy sector.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Janison Education Group reported a 9% revenue increase in FY25, driven by new contracts and the launch of its AI-powered assessment platform, Jai. The company also expanded its customer pipeline by 80%, positioning itself for sustained growth in digital education.

Janison Education Group reported a 9% revenue increase to $47 million in FY25, driven by new contracts and strong ICAS performance, while launching its AI-powered assessment platform Jai. The company also refreshed its leadership and expanded its customer pipeline to $28.6 million.

Lynch Group Holdings delivered solid FY25 results with revenue growth led by Australian supermarket floral demand and strong Chinese tulip exports, while FY26 outlook signals mixed conditions.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.